She received a state-of-the-art bio-implant that has miraculously regulated the condition with minimal invasiveness — and ...

One successful initiative in this field is the project of Kish Tissue Regeneration Corporation, which has played a key role in bio-implant development, supported by IDRO. This technology is currently ...

Explore why INmune Bio, Inc. is a speculative Strong Buy for high-risk investors. Click for the upcoming catalysts that make ...

Good afternoon ladies and gentlemen and welcome to the TELA Bio First Quarter 2025 Earnings ... So right now, we have 3 implant configurations. There's probably a fourth one coming at some point ...

Discover the top 4 undervalued Health Care Equipment & Supplies stocks for Tuesday, May 06 based on AAII’s Stock Grades.

Korro Bio, Inc. announced an interim readout from its Phase 1/2a clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) is expected in the second half of 2025, with trial completion ...

Here’s how a bio implant stopped Long Island woman’s ‘horrific’ arthritis in its tracks: ‘This is the future’ ...

The EV maker has already posted weaker-than-expected Q1 deliveries and analysts polled by Visible Alpha expect quarterly adjusted earnings per share (EPS) to have fallen by nearly 8% year-over ...

The tech titan reported revenue increased 13% year-over-year to $70.07 billion and profit of $3.46 per share, both above Visible Alpha consensus. Intelligent Cloud segment revenue jumped 21% to $ ...

PETALING JAYA: Bioalpha Holdings Bhd has proposed a RM110mil reduction of its issued share capital as part of a house keeping exercise of its balance sheet. In a filing with Bursa Malaysia ...